These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6096290)

  • 1. Relative uptake of low- and high-osmolality contrast media in CT of brain tumors.
    Fike JR; Cann CE; Norman D; Turrel JM; LeCouteur RA; Pflugfeld CM; Borcich JK
    Invest Radiol; 1984; 19(6 Suppl):S312-6. PubMed ID: 6096290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relative uptake of low- and high-osmolality contrast media in CT of brain tumors.
    Fike JR; Cann CE; Norman D; Turrel JM; LeCouteur RA; Pflugfelder CM; Borcich JK
    AJNR Am J Neuroradiol; 1984; 5(4):413-7. PubMed ID: 6431776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contrast enhancement of brain tumors and irradiated normal brain: a comparison of iohexol and iothalamate.
    Fike JR; Cann CE; Turowski K; Norman D; Ax L
    Neuroradiology; 1986; 28(1):61-4. PubMed ID: 3951691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of contrast media: experimental results in dog and man with CT implications.
    Gardeur D; Lautrou J; Millard JC; Berger N; Metzger J
    J Comput Assist Tomogr; 1980 Apr; 4(2):178-85. PubMed ID: 7365016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CT-determined canine kidney and urine iodine concentration following intravenous administration of sodium diatrizoate, metrizamide, iopamidol, and sodium ioxaglate.
    Brennan RE; Rapoport S; Weinberg I; Pollack HM; Curtis JA
    Invest Radiol; 1982; 17(1):95-100. PubMed ID: 7076442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A clinical trial of a new low osmolality contrast medium. Sodium and meglumine ioxaglate (Hexabrix) compared with meglumine iothalamate (Conray) for carotid arteriography.
    Grainger RG
    Br J Radiol; 1979 Oct; 52(622):781-6. PubMed ID: 389336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. X-ray phototherapy for canine brain masses.
    Norman A; Ingram M; Skillen RG; Freshwater DB; Iwamoto KS; Solberg T
    Radiat Oncol Investig; 1997; 5(1):8-14. PubMed ID: 9303051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computed tomographic characteristics of primary brain tumors in 50 dogs.
    Turrel JM; Fike JR; LeCouteur RA; Higgins RJ
    J Am Vet Med Assoc; 1986 Apr; 188(8):851-6. PubMed ID: 3710874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Computertomographic characteristics of primary brain tumors in dogs and cats].
    Fuchs C; Meyer-Lindenberg A; Wohlsein P; Nolte I
    Berl Munch Tierarztl Wochenschr; 2003; 116(9-10):436-42. PubMed ID: 14526475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of platelet function by contrast media: iopamidol and ioxaglate versus iothalamate. Work in progress.
    Rao AK; Rao VM; Willis J; Beckett C; Steiner RM
    Radiology; 1985 Aug; 156(2):311-3. PubMed ID: 4011893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of computed tomography and nephrography in quantitative comparison of urographic contrast agents.
    Wilson BC; Evill CA
    Radiology; 1981 Jul; 140(1):127-34. PubMed ID: 7244214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Computed tomography of intracranial chondroma with emphasis on delayed contrast enhancement.
    Tanohata K; Maehara T; Aida N; Unimo S; Matsui K; Mochimatsu Y; Fujitsu K
    J Comput Assist Tomogr; 1987; 11(5):820-3. PubMed ID: 3655044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of diatrizoate, iopamidol, and ioxaglate for the contrast enhancement of experimental hepatic tumors in CT.
    Burgener FA; Steinmetz SD
    Invest Radiol; 1985 Sep; 20(6):626-31. PubMed ID: 4066232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does dilution of contrast media affect contrast enhancement? An experimental study in rats.
    Dean PB; Kivisaari L; Kormano M
    Invest Radiol; 1988 Sep; 23 Suppl 1():S118-21. PubMed ID: 3198330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diagnosis of tumours in posterior cranial fossa by means of computerized tomography (author's transl)].
    Frankiewicz E; Rajszys R; Skweres W
    Pol Przegl Radiol Med Nukl; 1980; 44(2):109-14. PubMed ID: 6253960
    [No Abstract]   [Full Text] [Related]  

  • 16. Contrast enhancement of spontaneous animal CNS tumors with gadolinium DTPA: a correlation of MRI with x-ray CT.
    Goldstein EJ; Burnett KR; Wolf GL; Wortman J; Joseph P; Sen S
    Physiol Chem Phys Med NMR; 1985; 17(1):113-22. PubMed ID: 4034674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of patient responses to high- and low-osmolality contrast agents injected intravenously.
    Bagg MN; Horwitz TA; Bester L
    AJR Am J Roentgenol; 1986 Jul; 147(1):185-7. PubMed ID: 3487214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue fluid shifts during renal arteriography with conventional and low osmolality agents.
    Morris TW; Harnish PP; Reece K; Katzberg RW
    Invest Radiol; 1983; 18(4):335-40. PubMed ID: 6618823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of blood-brain barrier disruption by intracarotid iopamidol and methylglucamine iothalamate.
    Sage MR; Wilcox J; Evill CA; Benness GT
    AJNR Am J Neuroradiol; 1983; 4(4):893-5. PubMed ID: 6410875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contrast agent-induced thrombophlebitis following leg phlebography: meglumine loxaglate versus meglumine lothalamate.
    Thomas ML; Briggs GM; Kuan BB
    Radiology; 1983 May; 147(2):399-400. PubMed ID: 6340158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.